SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Bachman who wrote (396)7/2/1999 4:42:00 PM
From: RMP  Read Replies (2) of 534
 
I assume the last two posts are addressing this development:

biz.yahoo.com

I have to admit the mere fact that BJCT was collaborating with a company such as ELN got me interested in it in the first place. However, the press release appeared to suggest that the collaboration (BJCT/ELN) would reap royalties from GlucoTrax, should it turn a profit. Any thoughts about maintaining a position here or abandoning ship?

RMP

PS: Mark where are you?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News